PEIZER TERREN S

About PEIZER TERREN S

Terren S. Peizer is an American executive and investor best known for his long-standing association with Ontrak, Inc., where he played a central role in the company’s founding, growth, and governance. SEC filings describe him as the founder of Ontrak and note that he served as the company’s Chief Executive Officer and Chairman during its early development and expansion. In 2021, he moved into the role of Executive Chairman as Ontrak initiated a leadership transition, and he later returned as Chief Executive Officer in August 2022. He resigned from the board, as Chairman, as Executive Chairman, and as Chief Executive Officer in March 2023. Taken together, this shows a profile of a founder-operator deeply involved in both strategy and board leadership. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1136174/000162828022019376/ontrak-defproxystatement20.htm?utm_source=openai)) Beyond Ontrak, Peizer is described in public filings as an entrepreneur, investor, and financier with a broad background in healthcare, corporate finance, venture capital, and mergers and acquisitions. The SEC materials also indicate that he has held senior roles across multiple private and public companies, particularly in healthcare-related businesses. His affiliations have included BioVie, Inc., Verde, Inc., EVmo, Inc., ZipMo, Inc., and Casper Labs, while he also serves as Chairman of Acuitas Group Holdings, his personal investment vehicle. Through Acuitas and related entities, he has been associated with investments in micro-cap and small-cap companies, underscoring a long-term focus on growth-stage opportunities and active ownership. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1136174/000162828022019376/ontrak-defproxystatement20.htm?utm_source=openai)) His earlier career included senior positions in investment banking at Goldman Sachs, First Boston, and Drexel Burnham Lambert, which suggests experience in capital raising, structured finance, and transaction execution. Public documents also refer to him as having founded and commercialized several healthcare companies, which supports the view that his professional identity is centered on building and scaling businesses rather than managing a single operating role. Among the most notable corporate decisions connected to his name are the leadership transition at Ontrak in 2021, his return to the CEO role in 2022, and the subsequent board and executive changes in 2023. Because the available sources are primarily regulatory filings, the safest biographical framing is that of a healthcare-focused executive, investor, and founder with repeated leadership roles in public growth companies. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1136174/000162828022019376/ontrak-defproxystatement20.htm?utm_source=openai))